INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

PEREGRINE CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000764529)

Note: Option positions (PUT/CALL) are excluded.

Q1 2020
Shares 87,500 Value ($000) $5,509 Avg Close — Range —
Q4 2019
Shares 87,468 Value ($000) $10,839 Avg Close — Range —
Q3 2019
Shares 167,902 Value ($000) $11,142 Avg Close — Range —
Q2 2019
Shares 129,346 Value ($000) $10,292 Avg Close — Range —
Q1 2019
Shares 112,087 Value ($000) $12,538 Avg Close — Range —
Q4 2018
Shares 107,553 Value ($000) $10,840 Avg Close — Range —
Q3 2018
Shares 99,938 Value ($000) $12,628 Avg Close — Range —
Q2 2018
Shares 151,434 Value ($000) $12,707 Avg Close — Range —
Q1 2018
Shares 115,245 Value ($000) $7,090 Avg Close — Range —
Q4 2017
Shares 120,757 Value ($000) $7,055 Avg Close — Range —